Glutamate Metabotropic Receptor 7 (GRM7) Antibody
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
GRM7 Antibody is a Rabbit Polyclonal against GRM7.
Documents del producto
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Glutamate Metabotropic Receptor 7 (GRM7) |
| Host | Rabbit |
| Reactivity | Human |
| Recommended Dilution | IHC: 1/20 - 1/200. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Purification | Antigen Affinity Chromatography. |
| Size 1 | 20 µl |
| Size 2 | 50 µl |
| Size 3 | 100 µl |
| Size 4 | 200 µl |
| Size 5 | 1 ml |
| Form | Liquid |
| Tested Applications | ELISA, IHC |
| Buffer | PBS, pH 7.3, containing 0.02% sodium azide and 50% glycerol. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | Q14831 |
| Gene ID | 2917 |
| NCBI Accession | NP_000835.1, NM_000844.3, NP_870989.1, NM_181874.2 |
| OMIM | 604101 |
| Alias | GRM7,GLUR7,GPRC1G,MGLU7,MGLUR7,NEDSHBA,PPP1R87, mGluR7,mGlu7a receptor |
| Background | Antibody anti-GRM7 |
| Status | RUO |
Descripción
GRM7, or mGluR7, is a Group III metabotropic glutamate receptor widely expressed in the central nervous system, including the hippocampus, amygdala, and cerebellum. It functions as a presynaptic autoreceptor, coupling to Gi/o proteins to inhibit adenylate cyclase, decrease cAMP production, and suppress glutamate release. GRM7 plays a key role in synaptic plasticity, neuroprotection, and neuronal excitability, contributing to learning, memory, and emotional regulation. Dysregulation of GRM7 signaling is linked to psychiatric and neurological disorders, including anxiety, depression, schizophrenia, and epilepsy, where imbalanced glutamatergic transmission disrupts synaptic function. GRM7 activation has neuroprotective effects, reducing excitotoxicity and oxidative stress in neurodegenerative conditions. Positive allosteric modulators (PAMs) and selective agonists of GRM7 are being explored as therapeutic agents for anxiety, mood disorders, and epilepsy, highlighting its potential in restoring synaptic balance and neuroprotection.
Related Products
Glutamate Metabotropic Receptor 7 (GRM7) Antibody
Rabbit polyclonal antibody against GRM7 protein.
Ver Producto
Glutamate Metabotropic Receptor 7 (GRM7) Antibody
L-glutamate is the major excitatory neurotransmitter in the central nervous system, and it activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors that have been divided into three groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5, and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3, while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Multiple transcript variants encoding different isoforms have been found for this gene.
Ver Producto
Glutamate Metabotropic Receptor 7 (GRM7) Antibody
GRM7 Antibody is a Rabbit Polyclonal against GRM7.
Ver Producto